Phase 3 Study Data Shows Obeticholic Acid Could Treat NASH-Linked Fibrosis
Source: Pixabay.com

Phase 3 Study Data Shows Obeticholic Acid Could Treat NASH-Linked Fibrosis

According to a press release from American biotechnology company Intercept Pharmaceuticals, the company recently released additional data supporting its phase 3 clinical trial of obeticholic acid (OCA) in the treatment…

Continue Reading Phase 3 Study Data Shows Obeticholic Acid Could Treat NASH-Linked Fibrosis
New Study Shows Potential to Eliminate Osteonecrosis Risk in Osteoporosis and Brain Cancer Patients
Source: Pixabay.com

New Study Shows Potential to Eliminate Osteonecrosis Risk in Osteoporosis and Brain Cancer Patients

Biophosphonates (BPs) are common treatments for osteoporosis and metastatic bone cancer. They help to prevent bone loss. Unfortunately, these drugs can have serious side effects. One of the most severe…

Continue Reading New Study Shows Potential to Eliminate Osteonecrosis Risk in Osteoporosis and Brain Cancer Patients
Company Announces Plans for Myotonic Dystrophy and Duchenne Muscular Dystrophy Treatments
rawpixel / Pixabay

Company Announces Plans for Myotonic Dystrophy and Duchenne Muscular Dystrophy Treatments

According to a story from CRWE World, the genetic medicines company Audentes Therapeutics has recently announced its intent to develop new therapies for myotonic dystrophy and Duchenne muscular dystrophy. These…

Continue Reading Company Announces Plans for Myotonic Dystrophy and Duchenne Muscular Dystrophy Treatments

Experimental Drug for HPV-Linked Recurrent Respiratory Papillomatosis Shows Early Promise

According to a press release from Inovio Pharmaceuticals, the American biotech company's experimental recurrent respiratory papillomatosis (RRP) drug INO-3106 showed promising results at the end of a pilot clinical study…

Continue Reading Experimental Drug for HPV-Linked Recurrent Respiratory Papillomatosis Shows Early Promise

Immunotherapy Drug to be Tested for Autoimmune Hepatitis and Primary Sclerosing Cholangitis

According to a story from finanzen.at, the biotechnology company Orbsen Therapeutics recently announced that its immunotherapy product ORBCEL-C is to be tested in a multi-site clinical trial called MERLIN that…

Continue Reading Immunotherapy Drug to be Tested for Autoimmune Hepatitis and Primary Sclerosing Cholangitis

Clinical Trial Initiated for New Technology That Could Allow Amyotrophic Lateral Sclerosis Patients to Communicate

People living with rare diseases such as amyotrophic lateral sclerosis (ALS) or muscular dystrophy as well as those who have suffered from a stroke or spinal cord injury often experience…

Continue Reading Clinical Trial Initiated for New Technology That Could Allow Amyotrophic Lateral Sclerosis Patients to Communicate
Despite New Inflammatory Bowel Disease Therapies, Difficulty Treating Persists
source: pixabay.com

Despite New Inflammatory Bowel Disease Therapies, Difficulty Treating Persists

In a recent video interview with Healio, Dr. David Rubin recapped some of his discussion at the 2019 Interdisciplinary Autoimmune Summit. At the summit, he and his colleagues spoke about…

Continue Reading Despite New Inflammatory Bowel Disease Therapies, Difficulty Treating Persists
European Medicines Agency Okays Experimental Oral Mucositis Drug for Pediatric Investigation
Capri23auto / Pixabay

European Medicines Agency Okays Experimental Oral Mucositis Drug for Pediatric Investigation

According to a press release from American biotechnology company Soligenix, the European Medicines Agency's (EMA) Pediatric Committee recently agreed to the Company’s Pediatric Investigation Plan (PIP) for experimental oral mucositis…

Continue Reading European Medicines Agency Okays Experimental Oral Mucositis Drug for Pediatric Investigation